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CARDIOVASCULAR DISEASE 
Julia L. Verbiar, MS 
University of Pittsburgh, 2018
ABSTRACT 
Objective: It has been proposed that periodontitis and cardiovascular disease are related through a 
similar underlying inflammation pathway. There has also been suggestion of a genetic etiology 
connecting the two conditions. Further clarification of this proposed relationship has public health 
significance as both diseases affect over a quarter of the adult population of the United 
States. Using data from the Center from Oral Health Research in Appalachia cohort, we 
examined the relationship between periodontitis and cardiovascular disease. We then tested 
their association to candidate genetic loci to assess if the genetic loci may explain part of the 
relationship between the conditions. 
Methods and Results: Three indicators of periodontitis were developed; a molecular testing-
based variable (BANA, n=970) and two probing depth measurements, a liberal 
approximation that considered missing teeth as missing due to periodontitis (n=973) 
and a conservative one that did not (n=961). Personal and family history of heart disease and 
high blood pressure were condensed into a composite score indicative of cardiovascular 
disease (n=973). Four candidate single nucleotide polymorphisms (SNPs) were identified in 
the literature as related to both periodontitis and cardiovascular disease: rs10864294, rs4252120, 
rs1800795, and rs10965215.  Regression models were used to test the association between 
periodontitis and cardiovascular disease indicators and candidate SNPs with and without 
Thesis Director: John R. Shaffer, PhD 
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adjustment for covariates including age, sex, race, smoking status, and body mass 
index. Periodontitis and cardiovascular disease proxies were significantly associated with each 
other in unadjusted models (p<0.050). Heart disease score was not significantly associated with 
any candidate SNP, but both conservative and liberal probing depth-based indicators had a 
significant association with rs10864294 in models adjusted for covariates (p=0.003, p=0.006). 
BANA did not demonstrate a significant association with heart disease score or any candidate 
SNP. 
Conclusions: This study yielded support of the relationship between periodontitis and 
cardiovascular disease, but not an extension to the genetic level. Although rs10864294 was 
significantly associated with the probing depth periodontitis indicators, no candidate SNP was 
associated with heart disease score so it is not possible to conclude that any of these candidate 
SNPs explain the significant relationship seen between periodontitis and cardiovascular disease 
indicators.  
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1.0  INTRODUCTION 
Oral health is an important aspect of overall well-being, and research is continually 
uncovering additional components to support this connection. Recent studies have suggested that 
this relationship may even extend to a common genetic etiology between certain systemic 
diseases [1]. One example involving oral health is that the underlying inflammation pathway of 
chronic periodontitis may involve some of the same genes as that of cardiovascular disease [2]. 
According to the American Academy of Periodontology, periodontitis is a disease involving 
chronic inflammation and deterioration of the tissues and bone in the mouth [3]. If not treated 
properly, chronic periodontitis can lead to the separation of the gums from the teeth, eventually 
resulting in the loss of teeth. The onset and development of periodontitis is influenced by many 
components, including general oral health, the microbial environment of the mouth, and possibly 
shared genetic mutations that also cause systemic diseases such as cardiovascular disease 
[2]. Only recently has evidence supporting the genetic commonalities between periodontitis and 
cardiovascular disease been published, and there are some studies that contradict the claims, even 
though knowledge of the general connection has been well documented [1].  
A review article by Aarabi et al. summarized previous studies that looked at genetic loci 
related to both chronic periodontitis and coronary artery disease, a subtype of cardiovascular 
disease [1]. The identified loci, represented by their lead single nucleotide polymorphisms (SNPs) 
were identified through genome-wide association studies and are near genes associated with 
regulation of inflammation and the immune system: VAMP3, CAMTA1, PLG, ANRIL, CDKN2A, 
and CDKN2B. These genes are involved in controlling blood clotting, expression of immune 
system proteins in and growth of cardiovascular tissues, and demonstrate reciprocal regulation of 
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each other [1]. Further literature review identified another SNP, corresponding to the pro-
inflammatory cytokine interleukin-6, IL6, that has been shown to be associated with periodontitis 
and cardiovascular disease independently [4, 5]. 
This study intends to analyze further the link between periodontitis and cardiovascular 
health and determine if this association is found in  the initial cohort study of the Center for Oral 
Health Research in Appalachia (COHRA1).  Using data from COHRA1, composite phenotypes of 
periodontitis and cardiovascular disease will be used to test the significance of these SNPs reported 
by Aarabi et al. and similar studies.  Two specific aims have been developed to answer this 
question.   
• The first specific aim is to perform a literature review to assess current understanding of 
the similarities in the underlying genetic mechanism of periodontitis and cardiovascular 
disease.   
• The second specific aim is to perform statistical analyses to determine if the genetic 
commonalities identified in literature are supported by data from the COHRA1 study. This 
will be broken down into three main questions: 
• Are the candidate single nucleotide polymorphisms (SNPs) associated with 
medical or family history of cardiovascular disease? 
• Are the candidate SNPs associated with indicators of periodontal disease? 
• Are the indicators of periodontal disease associated with medical or family history 
of cardiovascular disease? If so, do any candidate SNPs explain part of the 
relationship between the periodontitis and cardiovascular disease variables?   
Gaining a further understanding of the significance of these genes relating to periodontitis, 
cardiovascular disease, and the relationship between the two will have multiple implications. 
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Understanding more about this genetic relationship is a significant public health concern because 
of the growing health care burden associated with both cardiovascular and periodontal diseases. 
Results will add to the literature regarding an underlying genetic relationship between these 
conditions, which can help with identifying individuals at risk for hereditary periodontitis and/or 
cardiovascular disease to allow the appropriate management of their health. This would be 
important for the fields of cardiovascular genetic counseling and dentistry as it could 
provide another piece of family history information that may be important to consider when 
determining risk of cardiovascular disease. The results of this study will be disseminated through 
a written report as well as presentations and meetings with medical and public health 
professionals.   
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2.0  LITERATURE REVIEW 
2.1 OVERVIEW OF PERIODONTAL DISEASE 
In general, periodontal disease refers to a range of chronic inflammatory diseases of the 
soft tissue, bone, and ligament in the mouth [2]. The mildest form, gingivitis, involves localized 
inflammation of the gums, leaving them red and swollen with a tendency to bleed easily. Gingivitis 
is often due to poor oral hygiene, which leads to and perpetuates the development of plaque and 
bacterial film on the teeth [2, 3]. If gingivitis is left untreated for an extended period of time, it can 
progress to periodontitis, a more severe condition involving the deterioration of gum tissue and 
attachment structures, eventually leading to tooth loss [2].  
Depending on its presentation, periodontitis can be classified as either an aggressive or a 
chronic form. Aggressive periodontitis has an isolated, rapid loss of attachment of teeth to 
supporting structures and has a stronger genetic component, while chronic periodontitis has a 
slower disease course, with prolonged development of pockets of recession prior to tooth loss [3]. 
These pockets are the hallmark of the disease, and they can indicate the severity of the loss of 
attachment as well as provide access for bacterial infection to further inflammation [3]. Chronic 
periodontitis is more common in adults, while aggressive periodontitis can also be seen in children 
[2]. Periodontitis is considered to be generalized if at least 10 of the 32 permanent teeth are 
affected, but it is more often seen that both chronic and aggressive periodontitis demonstrate site 
specificity [2].  
Due to the multifactorial aspect of periodontitis, different studies have attempted to 
measure the disease in different ways. Often, researchers derive the variables from the 
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understanding of the etiology of periodontitis at the time [6]. A common definition of periodontitis 
utilizes an established metric developed through a joint effort by the Centers for Disease Control 
and Prevention and the American Academy of Periodontology. In this definition, severe 
periodontitis is determined when at least two teeth have clinical attachment loss (CAL) of over 
6mm and periodontal probing depth (PPD) of over 5mm, while moderate periodontitis has two 
sites with over 4mm CAL or two with over 5mm PPD [7].  
As gingivitis progresses to periodontitis, there is a characteristic shift in the oral 
microbiome that triggers infection and inflammation. There are three main microbial species 
responsible for this shift: Porphyromonas gingivalis (P. gingivalis), Bacteroides forsythus (B. 
forsythus), and Treponema denticola (T. denticola) [8]. Interactions between these microbial 
species and others in the mouth shifts the symbiosis that maintains a state of oral health to dysbiosis 
that promotes the development of periodontitis [8]. These bacterial species are responsible for 
hydrolyzing benzoyl-DL-arginine-naphthylamide (BANA), a synthetic substrate; therefore, it is 
useful to test for the presence of this marker as a measure of periodontal infection [9]. The utility 
of testing BANA species is dependent on the sensitivity and specificity of culturing to assess the 
composition of the microbiome [10]. Studies have shown that the BANA test can have a similar 
effectiveness to DNA testing for the presence of the key microbial species involved in 
periodontitis, although it is not as useful a measurement after treatment for the condition [11].  
Treatment for periodontitis depends on the severity of the disease at the time of diagnosis. 
Diagnosis is based on clinical findings on exam as well as radiographic analysis of attachment and 
medical and dental history [12]. Periodontal screening should be performed as a routine part of 
dental care, with the frequency and extent of a full evaluation depending on whether or not a patient 
currently or previously showed signs of the disease [12]. It is relatively easy to prevent or reverse 
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the early signs of periodontitis with improved oral hygiene. The first step of treatment is a thorough 
cleaning of the teeth, or debridement, to remove plaque and biofilm buildup above and below the 
gum line that may be contributing to inflammation [2]. If there are signs of attachment loss or bone 
loss, further steps can involve medication and surgical intervention to reduce inflammation and 
maintain healthy dentition [2]. Some medications used are designed to specifically target the 
effects of the key microbial species associated with periodontitis, such as P. gingivalis [13]. 
Of the multiple known risk factors for periodontitis, some are modifiable, and others are 
not. The main modifiable risk factor is cigarette smoking because of the effect smoking has on the 
composition of the microbial community of the mouth, namely altering the quantity of particular 
bacterial species [14]. In one study, comparing the oral microbiome of smokers and non-smokers 
with chronic periodontitis in Korea, smokers were found to have higher levels of certain bacteria, 
including those of the genus Fusobacterium which have been linked to immunosuppression and 
periodontal attachment loss [14]. In general, smokers have worse outcomes in terms of rate of 
periodontitis, tooth loss, and response to treatment [2]. The effects of this are reversible, though, 
as smoking cessation can lead to an improvement in periodontal health measurements [15]. A 
systematic review in combination with meta-analysis of individual patient data showed that 
smoking cessation can reduce probing depths and increase clinical attachment level after the 
intervention of non-surgical treatment [15]. Another risk factor for periodontitis that can be 
partially modifiable is type-2 diabetes mellitus, as there is approximately a three-fold increased 
risk of developing periodontitis in individuals with diabetes [16]. Proper glycemic control is a key 
factor of periodontal health for patients with diabetes due to the systemic impact [16]. Studies 
show that there is a reciprocal relationship as the inflammatory response of periodontitis can alter 
glycemic control and elevated glucose levels can propagate the dysbiosis of the oral microbiome 
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[17]. Individuals with periodontitis and type-2 diabetes have increased insulin resistance and 
treatment for periodontitis can improve HbA1C levels, a diagnostic marker of diabetes [18]. The 
strength of the evidence for the relationship of periodontitis and type-2 diabetes has led to the 
suggestion that screening for periodontitis be implemented as part of a multidisciplinary approach 
to treating and managing diabetes [19]. It has also been suggested that predicting the impact of 
periodontitis on teeth and an individual’s response to treatment could be done in part based on 
gathering information about smoking and diabetes [20].  
Of the non-modifiable risk factors for periodontal disease, an area where the knowledge 
base has been growing is the genetic influence on disease. This risk factor is non-modifiable from 
the perspective that it is not possible to change an individual’s genes, however it is often possible 
to modify the impact of genes. The development of periodontal complex traits using principal 
component analysis has identified ten genetic loci with genome-wide significance for certain trait 
groups with variable pathogen loads in a study of 975 European American adults [21].  Of these 
loci, the majority include genes related to the epithelial barrier-related and immune function that 
impact the response to microbial species [21]. Other associations that have been connected to the 
genetics of the immune system are the pro-inflammatory cytokines called interleukins. 
Polymorphisms in a number of the different types of interleukins, which all have slightly different 
origins and functions, have been linked to periodontitis through meta-analysis studies [22, 23]. 
One such example is the association with interleukin-1 (IL-1), which is an activator of cytokines 
and adhesion molecules used by leukocytes, that showed significant association between the IL-
1β C(3953/4)T polymorphism and chronic periodontitis with an odds ratio indicating a greater risk 
of developing the disease for those individuals who are either homozygous or heterozygous for the 
T allele (OR=1.62, p=0.006) [24]. Interleukin-6 (IL-6), specifically at position -174 with a 
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polymorphism of a G to C substitution has been associated with both a susceptibility to chronic 
periodontitis as well as detection of P. gingivalis and Aggregatibacter actinomycetemcomitans (A. 
actinomycetemcomitans) [4, 25]. 
There are also genetic syndromes in which periodontitis is a common clinical feature, as 
seen by the identification of 15 results in ClinVar, a National Institutes of Health-curated database 
of genetic variants related to clinical phenotypes, and 31 in the Online Mendelian Inheritance in 
Man database [26–28]. One such disease is Haim-Munk syndrome that, in addition to periodontitis, 
is associated with dermatological findings and overgrowth of the fingernails and toenails [29]. This 
condition is known to be caused by mutations in the cathepsin C (CTSC) gene, that is related to 
differentiation of skin cells and gum tissues as well as immune function [29, 30]. CTSC is also 
associated with Papillon-Lefevre syndrome, which has many of the same features of Haim-Munk 
syndrome including periodontitis and dermatologic symptoms [31]. 
Poor oral health in general is a large public health concern, but periodontal disease is one 
of the most pressing issues in dental health [32]. In adults, periodontitis is one of the major causes 
of tooth loss which can lead to many other health concerns including poor nutrition and infection 
[33]. Addressing periodontal diseases, as well as other aspects of oral health, is one of the goals of 
the Healthy People 2020 initiative [34]. According to the National Health and Nutrition 
Examination Survey (NHANES) through 2012, 46% of the adult population of the United States 
had periodontitis, with 8.9% having severe disease [35]. This survey is a well-established, well-
validated tool for assessing trends in most aspects of health across the United States. It is possible, 
though, that these prevalence statistics may be lower than the actual rate, as it has been found that 
the NHANES protocol for evaluating periodontitis can underestimate periodontitis by as much as 
50%, based on the definition utilized in the particular version of the survey [36].  
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2.2 OVERVIEW OF CARDIOVASCULAR DISEASE 
Cardiovascular disease is a term that encompasses a broad range of medical conditions and 
concerns, as there are many aspects to heart health [37]. All the conditions that fall under the 
umbrella of cardiovascular disease have the common feature of a reduction in the ability of the 
heart and/or vasculature to function appropriately or effectively for blood circulation. Coronary 
artery disease is the most common type of cardiovascular disease, what is usually thought of with 
the term ‘heart disease,’ and involves the buildup of atherosclerotic plaques that restrict blood flow 
in arteries supplying blood to the heart [38]. A key component of heart disease is the involvement 
of the immune system and inflammation pathway in development of atherosclerotic plaques. Part 
of the buildup that blocks arteries comes from the accumulation of immune cells including 
macrophages and T cells recruited to the site of the fat streak that can turn into the fully formed 
plaque [39]. If allowed to progress without treatment, this can lead to chest pain, cramping of the 
heart muscle, and heart attack, also called myocardial infarction [40].  
Hypertension, or chronic high blood pressure, is another prevalent heart health issue, both 
on its own and as an indicator of more severe cardiovascular concerns [41]. Although blood 
pressure naturally changes throughout the day and after taxing activities such as exercise, this 
condition occurs when blood regularly pumps too forcefully through the arteries [41]. An 
individual is considered to be ‘hypertensive’ if their blood pressure is consistently elevated to 
140/90 mmHg or higher [42]. Those with blood pressure between 140-159/90-99 mmHg have 
stage 1 hypertension, and those with 160-179/100-109 mmHg have stage 2 hypertension [42]. 
Someone who has blood pressure readings consistently above normal, which is up to 120/80 
mmHg, but not into the hypertensive level, is considered to be pre-hypertensive and those with a 
blood pressure reading greater than 180/110 mmHg are considered to be in a hypertensive crisis 
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[42] . Without intervention, hypertension can lead to heart attack or stroke as well as heart failure 
or problems with other organ systems like the kidneys [42]. 
There are many risk factors that contribute to the onset and progression of cardiovascular 
disease, some of which are controllable and some of which are not. Those that are not controllable 
include age, sex, race, and family history [43]. Older individuals are more likely to develop heart 
disease or hypertension, as are males, and African Americans tend to have more severe 
hypertension which leads to an elevated rate of heart disease [43]. Family history is a complicated 
risk factor, because it can be influenced by multiple aspects that cluster in families, including both 
genetic risk and shared behaviors [44]. A familial predisposition is considered when there are first 
degree relatives who have myocardial infarctions at an early age, 55 years for males and 65 for 
females, but other factors, like a seemingly autosomal dominant pattern of myocardial infarction, 
can be considered in assessing family history [45]. Modifiable risk factors for cardiovascular 
disease include behaviors shared among family members, as lifestyle choices, such as diet, 
exercise, and smoking, affect the chance of developing cardiovascular disease.  
Another influence on the onset and progression of cardiovascular disease is the genetic 
component to an individual’s heart health. There have been genetic polymorphisms associated 
with many of the individual physiological risk factors that contribute to the development of 
cardiovascular disease. Searching in ClinVar yields 115 results of genetic loci linked to “coronary 
artery disease,” none of which overlap with those found for periodontitis [28, 46]. Using 
“hypertension,” ClinVar shows 1,107 variants while the Online Mendelian Inheritance in Man 
database, shows 771 entries, which includes specific genes in addition to genetic disorders [47, 
48]. Reviewing these results shows a large amount of overlap in entries, as well as many of the 
connections between cardiovascular health concerns and many other aspects of health. 
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Many of the loci and specific genes found to be linked with cardiovascular health 
phenotypes were identified using meta-analyses and association studies. In a large genome-wide 
association study of systolic and diastolic blood pressure in individuals of European descent, 
multiple loci related to hypertension, ventricular wall thickness, and stroke, as well as coronary 
artery disease overall, were found to be significant [49].  Genome-wide association studies have 
also identified genetic loci associated with the levels of circulating lipids that influence 
cardiovascular health [50]. Another circulatory molecule that has been related to influences on risk 
of cardiovascular disease is interleukin-6, a component of the immune system. Polymorphisms in 
this gene, -174G>C, have been associated with an increased susceptibility to coronary heart disease 
and severe cardiovascular events, as well as with periodontitis [5, 25, 51]. In a study from Scotland 
with 498 cases and 1109 controls, it was seen that those with the CC genotype had a lower risk of 
coronary heart disease than those with either the CG or GG genotype [51]. An analysis of data 
from the Cardiovascular Health Study looking at the relationship of the -174G>C loci and severe 
cardiac events showed that, in an elderly subset of the population, those with the -174C allele had 
a higher level of IL-6 which is indicative of a predisposition to atherosclerosis [5]. From an 
analysis of data from the Atherosclerosis Risk in Communities cohort, it has also been shown that 
incorporating genetic risk factors can be used in predicting incident coronary heart disease [52]. 
Inclusion of genetic loci nominally associated with incident coronary heart disease into a genetic 
risk score yielded models that acted as significant predictors of incident disease, even across races 
within the study  [52].  
Treatment of cardiovascular disease involves a variety of approaches depending on the 
extent of systemic involvement and the severity of the disease as well as certain predictors of 
response. Changing risky behaviors can have a vastly beneficial impact, even accounting for other 
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risk factors such as diabetes [53]. Many types of medications used in treatment of heart disease 
and hypertension have mechanisms of action that address different underlying causes of or possible 
complications from cardiovascular disease.  Patients tend to have varying levels of successful 
response, due in part to underlying genetic differences, and as such, heart health medication has 
been one of the first areas in which pharmacogenetics has really taken hold [54]. Research has 
shown that it is possible to predict the response a patient may have to certain drugs to know if it is 
a useful intervention, such as the impact of particular genetic loci on the risk of developing myalgia 
in patients who may be prescribed a statin medication [55]. Other medications for which a response 
can be anticipated based on genetics include anticoagulants and antiplatelet agents, the varying 
responses ranging from actually responding to the treatment to potentially negative side effects 
[56].  
There are many components to heart disease and there are many ways of measuring it, both 
directly and indirectly. Direct measurements include taking an individual’s blood pressure or other 
values based on physical exam or laboratory analysis. It is also possible to create a composite 
phenotype to evaluate the likelihood an individual has or would develop cardiovascular disease 
based on related risk factors [57]. Many studies utilized this approach; however, a true standard 
has not yet been developed. Analyzing cardiovascular health in terms of outcomes measurements 
involves looking at the rate or number of major adverse cardiovascular events (MACE), which 
includes stroke, myocardial infarction, and death [58]. It is possible, though, to use less severe 
indicators of heart health as a way of predicting or inferring heart disease. One study identified a 
method of using blood pressure, total cholesterol, and LDL cholesterol levels to predict heart 
disease in those who did not have a clear diagnosis [59].  
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Cardiovascular health is an enormous public health issue, as heart disease is the leading 
cause of death in the United States [60]. Approximately 11.7% of adults in the United States, which 
equates to 28.4 million people, have been diagnosed with heart disease [61]. The economic burden 
of heart health-related concerns in 2011 was over $320 billion: the estimated direct cost of 
cardiovascular disease was $195.6 billion, which includes hospital and health professional 
services, medications, and other aspects of care, and another $124.5 billion in loss due to premature 
death [62]. These numbers are only expected to rise, as it is predicted that by 2030, approximately 
40% of the population in the United States will have some type of cardiovascular health issue [63]. 
Addressing this trend and improving cardiovascular health is a major aim of public health 
initiatives across the country, in no small part as an attempt to curb the associated costs. 
2.3 CURRENT UNDERSTANDING OF THE RELATIONSHIP BETWEEN 
PERIODONTAL AND CARDIOVASCULAR HEALTH 
Over the course of the past few decades, there has been a steady stream of publications 
adding to the literature about the relationship between cardiovascular and periodontal disease. 
Enough data and discussion has been generated to warrant statements from a few national 
organizations overseeing developments in clinical practice and general understanding of their 
respective fields. From a joint consensus of The American Journal of Cardiology and Journal of 
Periodontology, there is acceptance of the possibility of periodontitis increasing the risk of 
cardiovascular disease, but hesitation in that there is not yet enough data to conclude a causal 
relationship [64]. This opinion is also found in the American Heart Association, with 
acknowledgement that an association between periodontal disease and a form of heart disease 
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called atherosclerotic vascular disease is supported by current data, however, it has not yet been 
shown to be causal [65]. 
The basis of the connection proposed between periodontitis and cardiovascular health is 
the underlying involvement of the inflammation pathway of the immune system in both diseases 
[1]. Initially, it was hypothesized that the inflammatory immune response was contributing to both 
more severe periodontal disease and an increased risk of coronary heart disease and other adverse 
cardiovascular events [66]. Part of this is due to the thought that oral infection leads to increased 
circulation of immune system molecules involved in the inflammation pathway [67].  One of the 
key factors thought to be involved with the systemic response of both diseases is C-reactive protein 
(CRP), an inflammatory marker associated with atherosclerosis [68]. Individuals with more severe 
inflammation from periodontitis have been seen to have increased CRP levels, which are 
associated with more pronounced cardiovascular health risks [68].  
Levels of the pathogens associated with periodontitis have been found to impact the 
progression of the atherosclerotic process [69]. The spread of microbial species like P. gingivalis 
from the oral cavity into the blood stream seems to exacerbate any inflammation that may be 
present in the vasculature, as determined by measuring the level of toll-like receptor (TLR), which 
is another marker of the immune system that serves as an atheroprotective factor in times of 
microbial infection [70, 71]. This effect, though, may be mediated by genetic susceptibility and 
other factors that are shared risk modifiers of the disease, like diet, smoking, and diabetes [72]. 
Additional evidence for the connection comes from the impact that treatment of one disease 
has on the other. Evaluation of probing pocket depth in patients with advanced chronic 
periodontitis showed that those who were on statin medication had a lower burden of disease than 
those who were not on the medication, suggesting that the difference came from the anti-
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inflammatory effect of the statin medication [73]. Patients taking statins had both lower a number 
of periodontal pockets and a smaller size of the pockets probed [73]. Treatment of periodontitis 
with antibiotics following debridement has also been shown to be associated with improved 
cardiovascular function in terms of measurements of pulse velocity and pressure [74]. A study 
comparing probing depth, bleeding, inflamed surface area, and other measurements of 
periodontitis and pulse pressure and velocity before and one year after treatment in 55 patients 
with severe untreated periodontitis disease showed reduction in those parameters that indicate 
more severe periodontitis and vascular health issues [74]. This further supports the idea that 
periodontal disease inflammation is contributing to cardiovascular disease risk as these are both 
anti-infective methods of treatment [74]. Using resolvins, anti-inflammatory mediators,  to treat 
periodontitis also shows a reduction in both local and systemic inflammation that can be part of 
the atherosclerosis process [75]. 
The relationship between periodontitis and cardiovascular disease has also been analyzed 
from the perspective of the time it takes for periodontitis to have this proposed effect. In a 
prospective cohort study by Yu et al, it was found that new cases of periodontal disease, or incident 
periodontal disease, increase the risk for women to have a severe cardiovascular health event [76]. 
Studies have shown that individuals with prevalent, or on-going, periodontal disease have 
increased risks for cardiovascular disease, but also that there can be a relatively rapid effect of 
periodontal inflammation on cardiac health outcomes including major cardiovascular disease, 
heart attack, and stroke [76]. 
To assess the genetic component of the link between periodontitis and cardiovascular 
disease, a common approach has been using genome-wide and candidate-gene association studies, 
but other analyses, such as twin studies, have also been used. A Swedish twin study found evidence 
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of shared genetic components on the basis of a positive correlation between coronary heart disease 
and periodontal disease, though not with tooth loss [77]. These calculations came from analysis of 
more broad “like-sex” twin pairs as well as monozygotic “like-sex” twin pairs to adjust for 
unaccountable genetic influences [77]. That study itself did not identify any genes that may be part 
of that correlation, but other work has found a few specific loci that may be responsible. For 
example, a candidate-gene association study of chromosome 9p21.3 identified significant 
association for both coronary heart disease and aggressive periodontitis, mapping to the noncoding 
RNA ANRIL, and the CDKN2A/CDKN2B genes, kinases that are two of the many genes ANRIL 
modifies [33]. This study looked only at single nucleotide polymorphism markers (SNPs) in the 
9p21.3 locus as it has been found to be significant in relation to atherosclerosis in more than a 
dozen genome-wide association studies [1]. The significance of ANRIL has been seen in both 
genome-wide association studies and candidate gene analysis [78]. Additional regions identified 
are chromosome 6q26 with the PLG gene, which is involved in binding bacteria, and chromosome 
1p36 with the VAMP3/CAMTA1 genes, both involved in the pathway of phagocytosis, and IL6, 
which is a pro-inflammatory cytokine, all of which are listed in Table 1 [1, 4, 5, 78]. These results, 
though not as numerous as the amount of genetic loci associated with cardiovascular disease and 
periodontitis individually, still demonstrate statistical significance [1]. The small number of 
genetic loci demonstrating statistical significance, and the lack of studies confirming proposed 
genetic links, are the main arguments made against the shared genetics of the relationship between 
periodontitis and cardiovascular disease. The statement from American Heart Association allows 
that there is a relationship between the two, however it has not yet been sufficiently shown to be 
causative or extend to a genetic level [65]. 
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Table 1. SNPs Reported to be Associated with both Periodontal and Cardiovascular Disease 
SNP Chromosomal Location Genes in Region 
rs10864294 1p36 VAMP3, CAMTA1 
rs4252120 6q26 PLG 
rs1800795 7p15.3 IL6 
rs10965215 9p21.3 ANRIL, CDKN2A, CDKN2B 
2.4 CENTER FOR ORAL HEALTH RESEARCH IN APPALACHIA 
The Center for Oral Health Research in Appalachia (COHRA) was created in 2002 as a 
joint effort between the University of Pittsburgh and West Virginia University to study disparities 
in oral health of the Northern Appalachian population in particular [79]. Appalachia spans portions 
of thirteen states from Mississippi to New York, with West Virginia being the only state fully 
encompassed by the region, as highlighted on the map in Figure 1 [79, 80]. The inhabitants of 
these areas are primarily Caucasian and of lower economic status, however, there is some 
variability. The recruitment area was intentional as a means of encompassing the social, cultural 
and economic aspects of rural Appalachia, though the cities and counties chosen are not necessarily 
fully representative of the entire county in which they are located [81]. The goal of the first cohort 
of COHRA (COHRA1) was to address the genetic, environmental, behavioral, and 
microbiological components that contribute to oral disease and tooth loss [82]. Much of the 
previous research out of COHRA1 has focused on caries, however data collected also included 
aspects of personal periodontal health and personal and family history of cardiovascular health. 
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Figure 1. Map of Appalachia. 
From the members involved with COHRA and the data that has been collected, a multitude 
of analyses have been conducted. Over 85 publications have come out of COHRA group, the 
majority of which focus on dental caries using COHRA1 data, though some that tend more towards 
proof of concept for the methods used, such as using genome-wide association studies or self-
report data. There have been only a few that have discussed to an appreciable extent the topics of 
periodontal or cardiovascular health, though they did not all use COHRA1 data. One publication 
that did use this data involved a genome-wide association study for genetic loci related to chronic 
periodontitis using probing depth in adults [83]. Ten loci with suggestive significance that had 
been previously associated with chronic periodontitis were identified, as were novel loci including 
the region near the gene OSBPL10, which is associated with hyperlipidemia [83]. Another project 
from members of the COHRA group that looked into periodontitis used Mendelian randomization 
analyses to incorporate body mass index-associated loci into a risk score and found total adiposity 
 19 
was not a causal risk factor for periodontitis [84]. There was also one study conducted that assessed 
the relationship of edentulism with cardiovascular disease and sleep disordered breathing, using 
data from the National Health and Nutrition Examination Survey, that found edentulism to be 
independently associated with cardiovascular disease [85]. There has not yet been a study that uses 
COHRA1 data to examine the link between periodontitis and cardiovascular disease. 
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3.0  MANUSCRIPT 
3.1 BACKGROUND 
Periodontitis is a disease in which the soft tissue, bone, and ligament of the structures 
surrounding the teeth deteriorate due to chronic inflammation [2]. This can either be an aggressive 
form, involving isolated, rapid loss of attachment, or chronic, which involves a slower disease 
course with the development of pockets of recession [2]. The onset of periodontitis is associated 
with a characteristic shift in the oral microbiome in three main species: Porphyromonas gingivalis 
(P. gingivalis), Bacteroides forsythus (B. forsythus), and Treponema denticola (T. denticola) [8].  
Measurement of periodontitis can involve analyzing the levels of these bacterial species indirectly, 
as they are all responsible for hydrolyzing benzoyl-DL-arginine naphthylamide (BANA) which is 
a useful marker of periodontal infection [6]. Clinical attachment loss (CAL) and periodontal 
probing depth (PPD), which are related to gum recession, are also measurements of periodontitis, 
as is a bleeding score based on probing of the gums [4].  
Risk factors for periodontitis include modifiable influences, such as dental hygiene 
practices and smoking, as well as non-modifiable influences, such as age and genetic 
polymorphisms. The genetic component is a more recent aspect of the understanding of 
periodontitis, in terms of the genetic contribution to risk for the disease and disease etiology. Many 
of the genetic loci found to be associated with periodontitis have been linked to the immune system 
and inflammatory response pathway [33]. One example is the pro-inflammatory cytokine 
interleukin 6, which is involved in immune system response and function [25]. This corresponds 
to the proposed link between periodontitis and cardiovascular disease, as they are thought to share 
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a similar underlying inflammation pathway as well as have influences on the onset and progression 
of the other disease [66]. 
The same pathogens that are the hallmark of periodontitis have been found to contribute to 
the progression of atherosclerotic plaques, a component of heart disease [69]. As the pathogens 
circulate in the blood stream, they are capable of perpetuating inflammatory responses initiated by 
the immune system in the vasculature that lead to plaque development [67]. This connection is 
also seen at the genetic level. For example, polymorphisms in the genes that produce various pro-
inflammatory cytokines, such as interleukins, have been linked to periodontitis through meta-
analyses [22, 23]. The same polymorphism in one subtype of interleukin, rs1800795 in IL6, has 
also been linked to susceptibility to cardiovascular disease in separate studies [5, 51]. In a study 
from Scotland and an analysis from the Cardiovascular Health Study, the -174G>C mutation in 
IL6 was associated with risk of coronary artery disease and severe cardiac events [5, 51]. 
In addition to those that look at the conditions individually, there have also been studies 
that directly examined the genetic link between periodontitis and cardiovascular disease. Multiple 
loci found to be significant for both periodontitis and cardiovascular disease, though not as many 
as have been implicated individually [1]. One such study is Aarabi et al, who reported a meta-
analysis that yielded three single nucleotide polymorphisms (SNPs) associated with both 
periodontitis and cardiovascular disease [1]. Data analyzed in this and similar studies involved 
using meta-analyses and genome-wide association methods to find these loci associated with 
periodontitis and/or cardiovascular disease. 
This study aims to examine the possible genetic basis of the relationship between 
periodontitis and cardiovascular disease, using data from the Center for Oral Health Research in 
Appalachia cohort 1 (COHRA1), which was a family-based study conducted in the Northern 
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Appalachia region examining oral health trends in the region. Variables related to periodontitis, 
including metrics of probing depth and BANA tests for microbial species, as well as cardiovascular 
disease, based on personal and family medical history, will be tested for their association with 
candidate SNPs identified in previous studies. Results of this study will further the understanding 
of the suggested genetic relationship between periodontitis and cardiovascular disease. 
3.2 METHODS 
3.2.1 Study Population 
The data used in this study are from the first study of the Center for Oral Health Research 
in Appalachia, known as COHRA1, which examined the disparities in oral health in Northern 
Appalachia (West Virginia and Western Pennsylvania) as compared to the rest of the United States. 
To gather this data, recruitment sites were established at multiple sites in West Virginia and 
Western Pennsylvania. Across those locations, 841 households with at least one adult parent of at 
least one biological child between the ages of 1 and 18 were enrolled [81]. These households came 
from mostly rural but a few metropolitan areas, and in general, the households had a variety of 
compositions in terms of biological relationships and ages of household inhabitants. The COHRA1 
sample comprises over 3,035 participants; however, for the analyses conducted in this study, 
participants were restricted to ages 18 and over with medical, oral health, and genotyping data, 
yielding 974 total participants. Institutional Review Board approval from the University of 
Pittsburgh IRB and West Virginia University IRB and informed consent were obtained.  
 23 
Genetic data was collected using SNP chip genotyping from biological samples obtained 
from participants including blood, buccal swabs and saliva. Genotyping of 580,000 SNPs was 
conducted on an Illumina platform [86]. Imputation was used to analyze more than one million 
additional SNPs with the help of the GENEVA consortium by the Center for Inherited Disease 
Research. 
For periodontal health, multiple variables were collected that can be used as markers or 
direct measurements of periodontitis. Subgingival plaque samples of the mesio-buccal sites of the 
four first molars and tongue scrapings were obtained for use in benzoyl-DL arginine-
naphthylamide (BANA) testing, using a kit from BANAMet [82]. The results of the test were 
scored as categorical variables as shown in Table 2. A dichotomous yes/no variable was created 
for BANA results (BANA) for those participants who had results for at least three of the five sites 
tested. Individuals who had a total score of at least 1 based on summing all five sites were coded 
as yes (1) and all others as no (0). 
Table 2. BANA Test Result Recording 
Test Result CFU Count of three BANA positive species Quantitative Variable  
Negative Less than 10,000 0 
Weak-Positive More than 10,000 but less than 100,000 1 
Positive More than 100,000 2 
 
A modified Periodontal Screening and Recording (PSR) exam that evaluated probing 
depth, recession, and bleeding was also performed by trained and calibrated hygienists to evaluate 
periodontal health [81]. These measurements, taken on participants over 17 years of age, were 
done for the reference teeth used for BANA measurements as well as an assessment of the whole 
mouth based on sectioning teeth into sextants, shown in Figure 2. For the sextants, the deepest 
PSR score for the teeth in each sextant was recorded, as shown in Table 3 [82]. Specific categories 
were created for sites indicating evidence of periodontal disease, such as the tooth being missing, 
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a pontic, or an implant [82]. The current study uses a proxy measurement of periodontitis by 
creating a dichotomous variable, with affection status defined as a probing depth measurement of 
at least 5.5mm for at least two teeth. A conservative approximation, periodontitis-related 
phenotype 1 (PSR1), was created that excluded missing measurements and coded the affection 
status as missing if there were not measurements for at least three of the sextants. A non-
conservative approximation (PSR2) was created that considered those teeth for which no 







Figure 2. Sextants for PSR Exam 
 
Table 3. PSR Score Recording for Reference Teeth and Sextants 
PSR Score Deepest Probing Depth in Sextant 
1 Less than 3.5 mm 
2 More than 3.5 mm but less than 5.5 mm 
3 More than 5.5 mm 
 
For cardiovascular health, the only direct measurement taken was a reading of blood 
pressure for participants at the beginning of their study visit. The rest of the data regarding 
cardiovascular health comes from the self-report health history forms that participants were asked 
to complete at each visit. Physical evaluation, medical history, and family history forms addressed 
various aspects of cardiovascular health by asking about personal medical history as well as 
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members of the participant’s family. Blood pressure was recorded on the physical evaluation form, 
along with any descriptive accounting of conditions regarding the participant’s heart such as 
medications [82]. The medical history form included questions about personal history of high 
blood pressure and heart disease and treatment [82]. The family history form included questions 
about heart disease and high blood pressure as well as which relatives were affected [82]. Aside 
from write-ins of personal treatment for high blood pressure or heart disease, information was 
recorded as yes/no responses. There was no precedent set in the literature for creating a compound 
phenotype of these variables, so for this study the responses were combined into a single, 
composite score of heart disease (HDSCORE) with a maximum possible value of 7, giving more 
weight to a personal history of heart disease and high blood pressure and less weight to those 
conditions in the family history, as outlined in Table 4. For a subset of participants who had 
observations from two visits, only the data for their second visit was used for all measurements, 
aside from carrying over the report of family history of high blood pressure or heart disease if it 
was only reported at the first visit. If no data was reported for either personal or family history of 
high blood pressure or heart disease, the participant was considered to be negative for that 
component of the HDSCORE variable. 
Table 4. HDSCORE Variable Quantification 
Variable Score 
Personal history heart disease 3 
Personal history high blood pressure 2 
Family history heart disease 1 
Family history high blood pressure 1 
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3.2.2 Identification of Genetic Polymorphisms 
To identify genetic loci associated with periodontitis and cardiovascular disease, search 
parameters were used including “periodontitis and cardiovascular disease,” “periodontitis and 
heart disease,” and “genetics of periodontitis and cardiovascular disease” in PubMed, a National 
Institutes of Health search engine [87]. From review of those results, four single nucleotide 
polymorphisms (SNPs) were selected based on the SNP being reported at least three times, 
including as part of other literature reviews, as well as the relevancy of the determination of the 
association with cardiovascular disease and periodontitis, based on recent reports within the past 
decade. Information on these SNPs is included in Table 5 [1, 88–91].  





SNP Genes in Region Minor Allele Frequencyb 
1p36 733260 rs10864294 VAMP3, CAMTA1 T=0.1867 
6q26 160722576 rs4252120 PLG C=0.1400 
7p15.3 22727026 rs1800795 IL6 C=0.1412 
9p21.3 22029446 rs10965215 ANRIL, CDKN2A, CDKN2B G=0.4593 
a Base Pair Location based on GRCh38.p7 
b Minor Allele Frequency based on 1000 Genomes Project 
3.2.3 Statistical Analysis 
Regression models were used to test the relationship between the periodontitis and 
cardiovascular disease variables and their association with the candidate SNPs in Table 1. Linear 
regression was used when the continuous HDSCORE variable was used as the outcome. Models 
were run using periodontitis indicators and each SNP as the predictors individually and together, 
both with and without adjustment for covariates of age, sex, race, smoking history, and BANA test 
results. Logistic regression was used when the dichotomous periodontitis indicators were the 
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outcome. These models were run using HDSCORE and each SNP as predictors, individually and 
together, with and without adjustment. Regression models were performed in STATA [92]. A post-
hoc power analysis was conducted for each model using the statistical software Quanto [93]. 
3.3 RESULTS 
This study explored the proposed phenotypic and genetic relationship between 
cardiovascular disease and periodontitis by modeling the phenotypic association between the two 
diseases and the genetic association of each disease with four candidate SNPs identified from the 
literature. These analyses were conducted using data from 973 adults from the COHRA1 cohort. 
Characteristics of the sample are shown in Table 6. The sample comprised relatively young adults, 
the majority of which were female (63.0%) and white (91.1%) with an average body mass index 
(BMI) of 29.7. For the periodontitis indicators: for the PSR1 definition, 20.2% of 961 participants 
had periodontitis; for the PSR 2 definition, 24.4% of 973 participants had periodontitis; for the 
BANA definition, 84.1% of 970 participants were positive. Of the 973 participants with an 
observation for HDSCORE, the mean score was 1.75, with a standard deviation of 1.2 and the 








Table 6. Summary of Covariates 
Population characteristic N Mean (SD) or percent 
Age 972 34.5 (9.3) 
Sex 
  
Female 612 63.0% 
Male 360 37.0% 
Race 
  
White 879 91.1% 
Other 86 8.9% 
Smoking status 
  
Current smoker 308 34.2% 
Never smoker 592 65.8% 
BMI 812 29.7 (7.7) 
PSR1 
  
        Affected 194 20.2% 
        Not Affected 767 79.8% 
PSR2 
  
        Affected 237 24.4% 
        Not Affected 736 75.6% 
BANA 
  
        Affected 806 84.1% 
        Not Affected 164 15.9% 
HDSCORE 973 1.75 (1.2) 
 
 

















Figure 4. HDSCORE Distribution 
 
Table 7 presents the relationships between the measures of periodontitis and cardiovascular 
disease. Specifically, we tested the association of HDSCORE with three indicators of periodontal 
disease, PSR1, PSR2, and BANA. There was a significant association between HDSCORE and 
both PSR1 and PSR2 in the univariate models. However, this association was not statistically 
significant in the covariate-adjusted model. In contrast, there was not a significant association 
between BANA and HDSCORE, in either univariate models or models adjusted for the covariates 
age, sex, race, and smoking status. Full details of the adjusted models can be seen in the 



















Table 7. Relationship between Periodontitis and Cardiovascular Disease Variables 















HDSCORE PSR1 0.192 0.097 0.048 - 0.116 0.108 0.281 - 
PSR2 0.196 0.090 0.030 - 0.091 0.101 0.367 - 
BANA  0.048 0.104 0.647 - 0.094 0.112 0.402 - 
PSR1 HDSCORE 0.127 0.064 0.049 1.135 0.084 0.078 0.280 1.088 
PSR2 HDSCORE 0.130 0.060 0.031 1.139 0.073 0.086 0.396 1.076 
BANA HDSCORE 0.033 0.072 0.646 1.034 0.054 0.078 0.490 1.055 
a Adjusted models include age, sex, race, smoking status, and BMI.  BANA was also included as a covariate in adjusted 
models except for models with BANA as the dependent variable or predictor 
Bold font indicates p-values less than 0.05 
 
Four candidate SNPs identified from the literature were tested for genetic association with 
indicators of both periodontitis and cardiovascular diseases. The associations between these SNPs 
and HDSCORE are shown in Table 8. No significant genetic associations were observed for 
HDSCORE. This was true in both the unadjusted and adjusted models, as well as those models 
that included the conservative PSR1 as a covariate to test for an association between the health 
outcomes when the SNPs were included. Because no association was seen between any SNP and 
the proxy variable of heart disease, it is not possible to conclude from this sample that any of these 
SNPs account for the association between the proxies of periodontitis and cardiovascular disease. 
Based on the post-hoc power calculations conducted, we expect to have had 80% power to detect 
effect sizes (beta coefficients) of 0.150 to 0.225 for these SNPs. Therefore, true associations with 






Table 8. Relationship between Cardiovascular Disease Variables and Candidate SNPs 
  Unadjusted model Adjusted model a 
SNP Beta Coefficient SE p-value Beta Coefficient SE p-value 
rs10864294 -0.099 0.082 0.226 -0.028 0.094 0.762 
rs4252120 -0.048 0.062 0.440 -0.076 0.068 0.264 
rs1800795 -0.025 0.055 0.647 -0.046 0.060 0.447 
rs10965215 -0.091 0.056 0.102 -0.098 0.061 0.110 
a Adjusted models include age, sex, race, smoking status, BANA, and BMI. 
 
One SNP, rs10864294, which corresponds to the VAMP3 and CAMTA1 genes, was 
significantly associated with PSR1 in the unadjusted model (p=0.031), as seen in Table 9 [88]. 
This relationship was also seen in the adjusted model, in which the SNP had statistical significance 
(p=0.003). The SNP had a similar effect on the PSR outcome odds ratios: with every additional 
copy of the major allele, an individual is between 0.580 and 0.714 times as likely to have 
periodontitis. The trends seen for each SNP in the models using PSR1 were echoed in the models 
using PSR2 in terms of direction of relationship indicated by the coefficient. The significance of 
the relationship between each SNP and PSR2 also mirrored that of PSR1 with one difference. The 
rs10864294 SNP did not have a statistically significant relationship with PSR2 in the unadjusted 
model (p=0.067), however, it did have a significant relationship with PSR2 in the adjusted model 
(p=0.006). Similar to PSR1, in the adjusted model, the magnitude of the effect of rs10864294 on 
the liberal periodontitis outcome was also greater, with an odds ratio of 0.621 as opposed to 0.762. 
None of the candidate SNPs were significantly associated with the dichotomous BANA indicator. 
For those SNPs that did not demonstrate a significant association with the periodontitis indicators, 
it is possible that this sample did not have the power to detect effect sizes of that magnitude, as 
post-hoc power calculations indicated that we expect to have 80% power to detect effect sizes of 
1.35 to 1.70.  
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Table 9. Relationship between Periodontitis Variables and Candidate SNPs 
    Unadjusted model Adjusted model a 














rs10864294 -0.337 0.157 0.031 0.714 -0.698 0.198 0.000 0.497 
rs4252120 0.087 0.130 0.502 1.091 0.166 0.152 0.273 1.181 
rs1800795 -0.024 0.113 0.831 0.976 -0.021 0.132 0.874 0.979 
rs10965215 -0.198 0.116 0.089 0.820 -0.173 0.136 0.203 0.841 
PSR2 
  
rs10864294 -0.272 0.148 0.067 0.762 -0.653 0.189 0.001 0.520 
rs4252120 0.063 0.120 0.602 1.065 0.152 0.142 0.285 1.164 
rs1800795 -0.780 0.105 0.460 0.458 -0.114 0.124 0.359 0.893 
rs10965215 -0.203 0.108 0.061 0.131 -0.144 0.128 0.261 0.866 
BANA 
  
rs10864294 -0.062 0.184 0.735 0.940 0.018 0.220 0.936 1.018 
rs4252120 0.035 0.136 0.798 1.036 0.036 0.155 0.815 1.037 
rs1800795 -0.076 0.124 0.539 0.927 -0.086 0.140 0.540 0.918 
rs10965215 0.039 0.124 0.750 1.040 -0.113 0.142 0.424 0.893 
aAdjusted models include age, sex, race, smoking status, and BMI.  BANA was also included as a covariate in adjusted 
models except for models with BANA as the dependent variable or predictor 
Bold font indicates p-value less than 0.05 
 
3.4 DISCUSSION 
The goal of this study was to test the association between periodontitis and cardiovascular 
disease and their link to candidate genetic loci identified through literature review. The COHRA1 
cohort from which the data was gathered was mostly relatively young and female, while 
individuals affected by periodontitis and/or cardiovascular disease are more commonly older and 
male [32, 38]. The majority of the participants were white, which allows for more accurate 
interpretation of the results as the majority of the studies looking at the genetics of cardiovascular 
disease and periodontitis were conducted in European populations [1].  
Data collected through a dental exam and self-report forms were used to create proxy 
variables as indicators of these two health conditions. For periodontitis, a dichotomous variable 
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based on the results of testing for the microbial species associated with the disease was used 
(BANA). This was not found to have a significant relationship with HDSCORE or the SNPs in 
any model. Two additional variables were used as indicators of periodontitis, both based on the 
results of periodontal probing depth. One of these was a conservative approximation (PSR1) that 
may have been an underrepresentation of the actual number of participants in the study with 
periodontal disease as this variable assumed that missing teeth were not missing due to 
periodontitis. The other approximation (PSR2) was liberal as it considered missing teeth to be 
evidence of periodontitis, which may be an overrepresentation of the affected subset of the study 
population. For both conservative and liberal definitions of periodontitis, disease misclassification, 
if present, would lead to a decrease in power to detect phenotypic and genetic associations. For 
cardiovascular disease, a composite score was created, weighting personal history of heart disease 
and personal history of high blood pressure over family history of either. Combining these into 
one score may have reduced the power to detect associations that are not shared by both heart 
disease and hypertension. 
In models unadjusted for covariates, the probing depth-based approximations were 
significantly associated with the heart disease score.  This finding corresponds with the current 
understanding in the field that there is an association between the two diseases, as has been 
acknowledged by professional bodies [65, 66]. This relationship went away when the covariates 
of age, sex, race, smoking status, and BANA test result were added to the model, suggesting that 
in the COHRA1 sample, the association between periodontitis and cardiovascular disease may be 
confounded by these factors.  
For three of the candidate SNPs, there was no statistical significance for the association 
between heart disease or periodontitis. rs1800795, which lies within an intron of the gene IL6, was 
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previously reported to be associated with both periodontitis and cardiovascular disease [4, 5, 94], 
but in this study, there was not a significant association of the SNP with either heart disease or 
periodontitis. As the IL6 cytokine is a known component of the inflammation response, the 
reported relationship of the genetic variant to periodontitis and heart disease was biologically 
plausible [95]; however, it was not supported by the results of this analysis. The rs4252120 SNP, 
within an intron of the gene PLG, which has been linked to the process of bacterial binding and is 
important  due to the involvement of pathogen-mediated inflammation in periodontitis and 
cardiovascular disease,  was also not found to be significant in relation to either periodontitis or 
heart disease [78, 96, 97]. rs10965215, linked to the non-coding RNA ANRIL, which lies within 
an intron of the CDKN2B gene and is known to modify the CDKN2A and CDKN2B genes that 
function as tumor suppressors, did not demonstrate a significant relationship with either indicators 
of periodontitis or cardiovascular disease, though it has been linked to atherosclerosis and 
regulation of the phagocytic mediator VAMP3  [98–102].  
The only SNP that was significantly associated with indicators of periodontitis was 
rs10864294. Significant associations were seen for PSR1 both in the unadjusted model and the 
model with additional covariates. This significance was seen for the adjusted models with both 
PSR1 and PSR2, however, in the unadjusted model PSR2 and rs10864294 did not demonstrate a 
significant relationship. The results for this SNP support the idea that there is a genetic component 
to periodontitis. The rs10864294 SNP corresponds to the genes VAMP3 and CAMTA1, linked to 
immune-mediated phagocytosis and tumor suppression respectively [1, 103, 104]. The C>T 
change of this SNP lies within the CAMTA1 gene, and changes a transcription factor binding site, 
POU6F1, that involves a bipartite DNA binding motif [105, 106]. This region has also been 
implicated in increased periodontal pathogen colonization, which has been associated with both 
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periodontitis progression and vascular inflammation [107]. These results demonstrate support of 
the relationship between periodontitis and cardiovascular disease, but not at the genetic level. This 
suggests that clinical care for individuals with either periodontitis or cardiovascular disease may 
be improved by adding in screening for the other condition.  Further research looking into this 
connection would clarify the most effective ways in which to make those connections. This could 
include adjusting analyses to demonstrate the effect of additional factors linked to periodontitis 
and cardiovascular disease, such as body mass index or diabetes. 
There are multiple limitations of the study, many of which are a product of the dataset used 
for the analysis. The COHRA study had a limited recruitment region, which restricted the diversity 
of participants included. Additionally, the statistical analysis did not account for the relatedness 
among participants in the sample which could have confounded the impact of the SNPs on each 
health outcome based on differences in allele frequency. Although the analysis was performed in 
adults from the households comprising mostly unrelated parents of children not included in this 
study, some known and cryptic biological relationships exist among the adults of the COHRA1 
sample. Another limitation based on the COHRA study protocol is the reliance on self-report data 
for personal and family health history, meaning it is conceivable that there was misreporting 
leading to inaccurate representations of the medical histories. There was also no clarification 
provided for the type of heart disease or number of family members with heart disease or high 
blood pressure. From these inexact measures of the health conditions in question, it possible that 
the composite variables created for periodontitis and cardiovascular disease do not adequately 
represent those with each disease. These sources of noise would reduce statistical power to detect 
associations. It is also possible that, based on the size and characteristics of the sample used, there 
was not adequate power to detect effects of the magnitude seen for the relationships between the 
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health outcomes. There are also multiple other genetic components that have been linked to both 
periodontitis and cardiovascular disease but were not explored in this analysis. 
3.5 CONCLUSION 
This study, which was designed to test the association of genetic variants identified through 
a literature search with both periodontitis and cardiovascular disease, demonstrated limited support 
for the genetic connection seen between the two health conditions. Without adjusting for 
covariates, there is evidence of a statistically significant association between periodontitis and 
cardiovascular disease. One SNP, rs10864294, corresponding to the VAMP3 and CAMTA1 genes 
involved in the phagocytosis pathway, was found to be significantly associated with periodontitis. 
These results support the hypothesis that there may be a genetic component to periodontitis but 
not to its association with cardiovascular disease, however, additional research is needed to explore 
this connection further. Knowledge of this potential genetic relationship would be useful to 
incorporate into clinical practice to more accurately assess individuals’ risk of either health 
condition, which is especially important at this time due to the large public health burden of both 
periodontitis and cardiovascular disease in the United States. 
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4.0  RESEARCH SIGNIFICANCE TO GENETIC COUNSELING AND PUBLIC 
HEALTH 
Our understanding of the implications of genetics on health is rapidly expanding as more 
aspects of the connection between DNA and disease are elucidated. As this information becomes 
incorporated into clinical practice and a part of the population’s general understanding of health, 
the crucial role of clinical genetics providers has vastly expanded. With the results of this study 
and others like it, genetic counselors and their colleagues have more information with which to 
help patients to improve health outcomes.  
Cardiovascular genetic medicine is one of the areas that has recently experienced major 
growth. The majority of cardiovascular diseases are multifactorial and involve not only a 
hereditary piece, but also lifestyle and environment factors [43]. To gauge the full extent of these 
components, health assessments during medical appointments include gathering medical history 
of the patient as well as social and behavioral history and family history. Research into the link 
between cardiovascular disease and other medical conditions helps providers adjust the review of 
personal and family histories to include all relevant information. Studies such as this, that show 
the significance of periodontitis and single nucleotide polymorphisms in relation to cardiovascular 
disease, add another question to ask of patients to get a more complete picture of the risk factors 
contributing to their cardiovascular health.  
An accurate assessment of an individual’s risk for cardiovascular disease is important 
because of the implications for managing their health in the most effective and appropriate way. 
Many aspects of cardiovascular health can be improved by lifestyle changes such as a healthier 
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diet and more exercise, but there are also certain genetic risk factors that can indicate which 
medications may be most effective [56].  
Genetic testing for periodontitis and cardiovascular disease, in terms of risk of developing 
the disease and not just determining treatment, is available. There are even direct to consumer tests 
for periodontal disease, meaning that there are not necessarily any health care providers involved 
in ordering the test or appropriately explaining the results [108]. It is difficult to ensure that medical 
professionals in fields other than genetics accurately understand the results and implications of 
genetic testing, and it is often even more difficult to ensure that understanding for the general 
population. Due to the availability of these tests, and the deepening knowledge base about the 
connections between genetics and all aspects of health, including dental health, it is more important 
than ever to be diligent about educating as many medical professionals as possible to be able to 
interpret genetic test results, and refer on to genetics specialists appropriately. Genetic counselors 
are uniquely trained to be able to explain genetic information to patients and providers and serve 
as an invaluable resource. This is especially true in situations where the genetic component of an 
individual’s health may play a previously unknown role, such as with periodontal disease when 
the understanding of genetic causes is still relatively new.  
With the results of this study and similar work, there is the possibility that some of those 
connections may be applied to treatment of periodontitis as well. In addition to being critical for 
proper patient care, appropriate management of these conditions has a broader impact due to the 
public health burden of both cardiovascular disease and periodontitis. An increasing percentage of 
the population with cardiovascular health problems. Heart disease has become the leading cause 
of death in the United States, while periodontitis is one of the major causes of tooth loss, which 
can exacerbate or lead to many other concerns [33]. Addressing these trends is important to 
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improve the health of such a large subset of the country as well as reduce the burden on the 
healthcare system of the direct and indirect costs of treatment, especially of those with 
cardiovascular disease [62].  
Tackling this burden requires addressing the issue of improving access to health care, the 
greatest barrier of which is the prohibitive cost of services and insurance [109]. Health insurance 
is most often obtained through employment, meaning that individuals who are unemployed may 
have a harder time accessing care, and more individuals have medical insurance than they do 
dental, so they may not have the ability to afford care for periodontitis even if a cardiovascular 
health evaluation or genetic markers indicate that it is warranted [110]. Provider education and 
increased awareness of the importance of dental care on multiple aspects of health may be a way 
to improve recognition of the crucial need for broader access to dental care by validating the cost 
of the services. As the American Dental Association contends, the value of a clinical exam in 
identifying periodontal disease cannot be replaced by genetic testing or other indicators alone 
[111]. 
Research that identifies potential ways of measuring individuals’ risk of developing 
cardiovascular disease, and periodontitis is a component of tackling this public health problem 
through multiple areas of the essential public health services. With the results of this study and 
others like it, it is possible to “evaluate [the] effectiveness… of personal…health services” to 
ensure that health professionals are delivering care using the most accurate information [112]. 
Along those lines, this research can also provide “new insights and innovative solutions to health 
problems” by providing additional information that can be used to address the health of those at 
risk for or with cardiovascular health disease and periodontitis [112]. 
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The results of this study are also applicable on a more individual scale. There are some 
previously characterized, relatively rare genetic disorders involving an increased risk of 
periodontitis, including Haim-Munk syndrome and Papillon-Lefevre syndrome [113]. With further 
evidence towards the relationship between periodontitis and cardiovascular disease, it may be 
determined that adding cardiology evaluations for the management of these patients to fully assess 
their clinical picture is a necessary part of routine care. The particular SNPs evaluated in this study 
are not in the genes noted to cause these conditions; however, further analysis could show that 




APPENDIX A: SUPPLEMENTAL TABLES 
Table 10. Relationship between Periodontitis and HDSCORE adjusted for covariates 
Dependent Predictor Beta Coefficient SE P-value OR 
HDSCORE PSR1 0.116 0.108 0.281  - 
  Age 0.034 0.005 0.000  - 
  Sex  -0.008 0.090 0.925  - 
  Race 0.324 0.146 0.027  - 
  Smoking  -0.057 0.094 0.544  - 
  BANA 0.099 0.113 0.383  - 
  BMI 0.026 0.006 0.000  - 
  
HDSCORE PSR2  0.091 0.101 0.367  - 
  Age 0.033 0.005 0.000  - 
  Sex -0.020 0.089 0.820  - 
  Race  0.331 0.146 0.024  - 
  Smoking -0.060 0.093 0.520  - 
  BANA 0.094 0.112 0.403  - 
  BMI 0.028 0.006 0.000  - 
    
HDSCORE BANA 0.094 0.112 0.402  - 
  Age 0.034 0.005 0.000  - 
  Sex -0.031 0.088 0.728  - 
  Race  0.344 0.145 0.018  - 
  Smoking -0.049 0.092 0.597  - 
  BMI 0.028 0.006 0.000  - 
    
PSR1 HDSCORE 0.084 0.078 0.280 1.088 
  Age  0.043 0.010 0.000 1.044 
  Sex -0.686 0.188 0.000 0.504 
  Race 0.830 0.395 0.036 2.293 
  Smoking  0.506 0.203 0.013 1.659 
  BANA 0.154 0.250 0.538 1.166 
  BMI 0.004 0.013 0.752 1.004 
    
PSR2 HDSCORE 0.070 0.074 0.344 1.073 
  Age  0.057 0.010 0.000 1.058 
  Sex -0.608 0.178 0.001 0.545 
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  Race 0.980 0.378 0.009 2.665 
  Smoking  0.702 0.191 0.000 2.018 
  BANA -0.011 0.228 0.963 0.990 
  BMI -0.002 0.012 0.862 0.998 
    
BANA HDSCORE 0.073 0.086 0.396 1.076 
  Age  -0.018 0.011 0.101 0.982 
  Sex -0.405 0.208 0.052 0.667 
  Race -0.839 0.415 0.044 0.432 
  Smoking  -0.467 0.204 0.022 0.627 
  BMI -0.004 0.013 0.757 0.996 
 
Table 11. Relationship between HDSCORE and candidate SNPs adjusted for covariates 
Dependent Predictor Beta Coefficient SE p-value 
HDSCORE rs10864294 -0.028 0.094 0.762 
  Age 0.035 0.005 0.000 
  Sex  -0.028 0.089 0.755 
  Race 0.345 0.164 0.036 
  Smoking  -0.045 0.093 0.626 
  BANA 0.094 0.113 0.405 
  BMI 0.028 0.006 0.000 
          
HDSCORE rs4252120 -0.076 0.068 0.264 
  Age 0.034 0.005 0.000 
  Sex -0.030 0.088 0.737 
  Race  0.341 0.146 0.020 
  Smoking -0.046 0.092 0.616 
  BANA 0.094 0.112 0.399 
  BMI 0.028 0.006 0.000 
          
HDSCORE rs1800795 -0.046 0.060 0.447 
  Age 0.034 0.005 0.000 
  Sex -0.030 0.090 0.736 
  Race  0.358 0.147 0.015 
  Smoking -0.061 0.093 0.514 
  BANA 0.092 0.115 0.425 
  BMI 0.029 0.006 0.000 
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HDSCORE rs10965215 -0.098 0.061 0.110 
  Age  0.033 0.005 0.000 
  Sex -0.032 0.088 0.714 
  Race 0.340 0.145 0.019 
  Smoking  -0.053 0.092 0.562 
  BANA 0.085 0.112 0.445 
  BMI 0.028 0.006 0.000 
 
Table 12.  Relationship between CVD and candidate SNPs adjusted for covariates and PSR1 
Dependent Predictor Beta Coefficient SE p-value 
HDSCORE rs10864294 -0.042 0.096 0.665 
  Age 0.034 0.005 0.000 
  Sex  -0.006 0.091 0.945 
  Race 0.337 0.166 0.043 
  Smoking  -0.053 0.095 0.579 
  BANA 0.100 0.114 0.381 
  BMI 0.027 0.006 0.000 
  PSR1 0.107 0.109 0.324 
  
HDSCORE rs4252120 -0.085 0.068 0.215 
  Age 0.034 0.005 0.000 
  Sex -0.007 0.090 0.939 
  Race  0.320 0.147 0.030 
  Smoking -0.055 0.094 0.555 
  BANA 0.099 0.113 0.379 
  BMI 0.027 0.006 0.000 
  PSR1 0.121 0.108 0.261 
  
HDSCORE rs1800795 -0.041 0.061 0.502 
  Age 0.034 0.005 0.000 
  Sex -0.008 0.091 0.932 
  Race  0.337 0.148 0.023 
  Smoking -0.071 0.095 0.458 
  BANA 0.097 0.116 0.403 
  BMI 0.028 0.006 0.000 




Table 12 Continued 
HDSCORE rs10965215 -0.092 0.062 0.136 
  Age  0.033 0.005 0.000 
  Sex -0.011 0.090 0.904 
  Race 0.320 0.146 0.029 
  Smoking  -0.063 0.094 0.504 
  BANA 0.090 0.113 0.426 
  BMI 0.027 0.006 0.000 
  PSR1 0.113 0.108 0.296 
 
Table 13. Relationship between indicators of periodontitis and SNPs adjusted for covariates 
Dependent Predictor Beta Coefficient SE p-value OR 
PSR1 rs10864294 -0.698 0.198 0.000 0.498 
  Age 0.046 0.010 0.000 1.047 
  Sex  -0.709 0.191 0.000 0.492 
  Race 1.305 0.447 0.003 3.689 
  Smoking  0.500 0.205 0.015 1.648 
  BANA 0.157 0.252 0.534 1.170 
  BMI 0.004 0.013 0.770 1.004 
  
PSR1 rs4252120 0.157 0.152 0.301 1.170 
  Age 0.046 0.010 0.000 1.047 
  Sex -0.689 0.188 0.000 0.502 
  Race  0.855 0.395 0.031 2.350 
  Smoking 0.501 0.203 0.014 1.651 
  BANA 0.163 0.250 0.513 1.177 
  BMI 0.006 0.013 0.616 1.006 
  
PSR1 rs1800795 -0.027 0.131 0.835 0.973 
  Age 0.046 0.010 0.000 1.047 
  Sex -0.646 0.191 0.001 0.524 
  Race  0.996 0.417 0.017 2.706 
  Smoking 0.531 0.206 0.010 1.700 
  BANA 0.125 0.255 0.625 1.133 
  BMI 0.009 0.013 0.469 1.009 
  
PSR1 rs10965215 -0.182 0.136 0.180 0.834 
  Age  0.046 0.010 0.000 1.047 
  Sex -0.676 0.189 0.000 0.508 
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  Race 0.861 0.395 0.029 2.366 
  Smoking  0.497 0.204 0.015 1.644 
  BANA 0.159 0.250 0.525 1.172 
  BMI 0.006 0.013 0.634 1.006 
  
PSR2 rs10864294 -0.651 0.190 0.001 0.521 
  Age 0.058 0.010 0.000 1.060 
  Sex  -0.630 0.180 0.000 0.533 
  Race 1.422 0.428 0.001 4.144 
  Smoking  0.692 0.192 0.000 1.997 
  BANA -0.015 0.230 0.948 0.985 
  BMI -0.003 0.012 0.830 0.997 
  
PSR2 rs4252120 0.145 0.142 0.306 1.156 
  Age 0.059 0.010 0.000 1.061 
  Sex -0.612 0.178 0.001 0.542 
  Race  0.999 0.378 0.008 2.716 
  Smoking 0.695 0.191 0.000 2.004 
  BANA -0.003 0.228 0.988 0.997 
  BMI 0.000 0.012 0.986 1.000 
  
PSR2 rs1800795 -0.118 0.124 0.338 0.888 
  Age 0.060 0.010 0.000 1.061 
  Sex -0.556 0.181 0.002 0.574 
  Race  1.125 0.396 0.004 3.081 
  Smoking 0.719 0.194 0.000 2.052 
  BANA -0.073 0.232 0.753 0.929 
  BMI 0.003 0.012 0.792 1.003 
  
PSR2 rs10965215 -0.152 0.128 0.235 0.859 
  Age  0.060 0.010 0.000 1.062 
  Sex -0.597 0.178 0.001 0.550 
  Race 1.012 0.378 0.007 2.750 
  Smoking  0.696 0.191 0.000 2.007 
  BANA -0.003 0.228 0.988 0.997 
  BMI -0.001 0.012 0.964 0.999 
  
BANA rs10864294 -0.650 0.190 0.001 0.522 
  Age 0.058 0.010 0.000 1.059 
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  Sex  -0.646 0.179 0.000 0.524 
  Race 1.422 0.428 0.001 4.144 
  Smoking  0.709 0.191 0.000 2.032 
  BMI -0.002 0.012 0.835 0.998 
  
BANA rs4252120 0.138 0.142 0.328 1.148 
  Age 0.059 0.010 0.000 1.060 
  Sex -0.629 0.177 0.000 0.533 
  Race  0.999 0.377 0.008 2.716 
  Smoking 0.712 0.190 0.000 2.038 
  BMI 0.000 0.012 0.993 1.000 
  
BANA rs1800795 -0.125 0.123 0.312 0.883 
  Age 0.059 0.010 0.000 1.061 
  Sex -0.570 0.180 0.002 0.565 
  Race  1.131 0.395 0.004 3.099 
  Smoking 0.740 0.193 0.000 2.096 
  BMI 0.003 0.012 0.785 1.003 
  
BANA rs10965215 -0.168 0.127 0.188 0.846 
  Age  0.059 0.010 0.000 1.061 
  Sex -0.613 0.177 0.001 0.542 
  Race 1.013 0.377 0.007 2.755 
  Smoking  0.712 0.190 0.000 2.037 
  BMI 0.000 0.012 0.968 1.000 
 
Table 14. Relationship between indicators of periodontitis and SNPs adjusted for covariates and HDSCORE 
Dependent Predictor Beta Coefficient SE p-value OR 
PSR1 rs10864294 -0.698 0.198 0.000 0.497 
  Age 0.043 0.011 0.000 1.044 
  Sex  -0.710 0.191 0.000 0.492 
  Race 1.284 0.447 0.004 3.612 
  Smoking  0.505 0.205 0.014 1.658 
  BANA 0.146 0.253 0.564 1.157 
  BMI 0.001 0.013 0.941 1.001 




Table 14 Continued 
PSR1 rs4252120 0.166 0.152 0.273 1.181 
  Age 0.043 0.010 0.000 1.044 
  Sex -0.689 0.188 0.000 0.502 
  Race  0.831 0.396 0.036 2.296 
  Smoking 0.504 0.204 0.013 1.656 
  BANA 0.154 0.250 0.539 1.166 
  BMI 0.003 0.013 0.792 1.003 
  HDSCORE 0.089 0.078 0.254 1.093 
  
PSR1 rs1800795 -0.021 0.132 0.874 0.979 
  Age 0.043 0.011 0.000 1.044 
  Sex -0.646 0.191 0.001 0.524 
  Race  0.971 0.418 0.020 2.642 
  Smoking 0.536 0.206 0.009 1.708 
  BANA 0.116 0.255 0.650 1.123 
  BMI 0.006 0.013 0.624 1.006 
  HDSCORE 0.085 0.079 0.284 1.089 
  
PSR1 rs10965215 -0.173 0.136 0.203 0.841 
  Age  0.044 0.011 0.000 1.045 
  Sex -0.677 0.189 0.000 0.508 
  Race 0.838 0.396 0.034 2.312 
  Smoking  0.500 0.204 0.014 1.649 
  BANA 0.151 0.251 0.546 1.163 
  BMI 0.003 0.013 0.792 1.003 
  HDSCORE 0.081 0.078 0.298 1.085 
  
PSR2 rs10864294 -0.653 0.189 0.001 0.520 
  Age 0.056 0.010 0.000 1.057 
  Sex  -0.630 0.180 0.000 0.533 
  Race 1.406 0.429 0.001 4.079 
  Smoking  0.697 0.193 0.000 2.008 
  BANA -0.024 0.230 0.916 0.976 
  BMI -0.005 0.012 0.684 0.995 
  HDSCORE 0.071 0.074 0.338 1.074 
  
PSR2 rs4252120 0.152 0.142 0.285 1.164 
  Age 0.057 0.010 0.000 1.058 
  Sex -0.612 0.178 0.001 0.542 
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  Race  0.980 0.379 0.010 2.664 
  Smoking 0.699 0.191 0.000 2.012 
  BANA -0.011 0.228 0.962 0.989 
  BMI -0.003 0.012 0.825 0.997 
  HDSCORE 0.074 0.074 0.318 1.077 
  
PSR2 rs1800795 -0.114 0.124 0.359 0.893 
  Age 0.057 0.010 0.000 1.059 
  Sex -0.556 0.181 0.002 0.574 
  Race  1.107 0.397 0.005 3.025 
  Smoking 0.723 0.194 0.000 2.061 
  BANA -0.079 0.232 0.733 0.924 
  BMI 0.001 0.012 0.941 1.001 
  HDSCORE 0.066 0.075 0.377 1.069 
  
PSR2 rs10965215 -0.144 0.128 0.261 0.866 
  Age  0.058 0.010 0.000 1.059 
  Sex -0.597 0.178 0.001 0.550 
  Race 0.993 0.379 0.009 2.698 
  Smoking  0.700 0.191 0.000 2.015 
  BANA -0.010 0.228 0.966 0.990 
  BMI -0.003 0.012 0.818 0.997 
  HDSCORE 0.069 0.074 0.355 1.071 
  
BANA rs10864294 0.018 0.220 0.936 1.018 
  Age -0.019 0.011 0.088 0.981 
  Sex  -0.417 0.210 0.048 0.659 
  Race -0.734 0.447 0.101 0.480 
  Smoking  -0.499 0.205 0.015 0.607 
  BMI -0.004 0.013 0.752 0.996 
  HDSCORE 0.073 0.086 0.401 1.075 
  
BANA rs4252120 0.036 0.155 0.815 1.037 
  Age -0.018 0.011 0.100 0.982 
  Sex -0.407 0.208 0.051 0.666 
  Race  -0.821 0.416 0.048 0.440 
  Smoking -0.467 0.204 0.022 0.627 
  BMI -0.004 0.013 0.756 0.996 
  HDSCORE 0.073 0.086 0.393 1.076 
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BANA rs1800795 -0.086 0.140 0.540 0.918 
  Age -0.016 0.011 0.162 0.984 
  Sex -0.355 0.212 0.094 0.701 
  Race  -0.783 0.417 0.060 0.457 
  Smoking -0.425 0.209 0.043 0.654 
  BMI -0.003 0.013 0.809 0.997 
  HDSCORE 0.071 0.088 0.419 1.074 
  
BANA rs10965215 -0.113 0.142 0.424 0.893 
  Age  -0.019 0.011 0.081 0.981 
  Sex -0.409 0.209 0.050 0.664 
  Race -0.839 0.415 0.043 0.432 
  Smoking  -0.471 0.204 0.021 0.624 
  BMI -0.004 0.013 0.785 0.996 
  HDSCORE 0.065 0.086 0.448 1.068 
 
Table 15. Post-Hoc Power Calculations showing effect sizes necessary to achieve 80% power for each combination 
of condition and SNP 
Outcome SNP Effect 



































1. Aarabi G, Zeller T, Seedorf H, Reissmann DR, Heydecke G, Schaefer AS, et al. Genetic 
susceptibility contributing to periodontal and cardiovascular disease. J Dent Res. 
2017;96:610–617. doi:10.1177/0022034517699786. 
2. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 
2017;3:17038. doi:10.1038/nrdp.2017.38. 
3. Types of Gum Disease | Perio.org. https://www.perio.org/consumer/types-gum-disease.html. 
Accessed 16 Aug 2017. 
4. Trevilatto PC, Scarel-Caminaga RM, de Brito RB, de Souza AP, Line SRP. Polymorphism at 
position -174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a 
Caucasian Brazilian population. J Clin Periodontol. 2003;30:438–442. 
doi:10.1034/j.1600-051X.2003.20016.x. 
5. Jenny NS, Tracy RP, Ogg MS, Luong LA, Kuller LH, Arnold AM, et al. In the elderly, 
interleukin-6 plasma levels and the -174G>C polymorphism are associated with the 
development of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:2066–
2071. 
6. Jacob P S. Measuring periodontitis in population studies: a literature review. Revista odonto 
ciencia. 2011. 
7. Rozier RG, White BA, Slade GD. Trends in oral diseases in the U.S. population. J Dent Educ. 
2017;81:eS97–eS109. doi:10.21815/JDE.017.016. 
8. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. 
Nat Rev Immunol. 2015;15:30–44. doi:10.1038/nri3785. 
9. Loesche WJ, Giordano J, Hujoel PP. The utility of the BANA test for monitoring anaerobic 
infections due to spirochetes (Treponema denticola) in periodontal disease. J Dent Res. 
1990;69:1696–1702. doi:10.1177/00220345900690101301. 
10. Ivic-Kardum M, Beader N, Staudt-Skaljac G. Diagnostic Methods for Evaluation of 
Microbial Flora in Periodontitis. Acta Stomatol Croat. 2000. 
11. Andrade JA de, Feres M, Figueiredo LC de, Salvador SL, Cortelli SC. The ability of the 
BANA test to detect different levels of P. gingivalis, T. denticola and T. forsythia. Braz 
Oral Res. 2010;24:224–230. doi:10.1590/S1806-83242010000200016. 
12. Preshaw PM. Detection and diagnosis of periodontal conditions amenable to prevention. 
BMC Oral Health. 2015;15 Suppl 1:S5. doi:10.1186/1472-6831-15-S1-S5. 
13. Kataoka S, Baba A, Suda Y, Takii R, Hashimoto M, Kawakubo T, et al. A novel, potent dual 
inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal 
disease therapy. FASEB J. 2014;28:3564–3578. doi:10.1096/fj.14-252130. 
 57 
14. Moon JH, Lee JH, Lee JY. Subgingival microbiome in smokers and non-smokers in Korean 
chronic periodontitis patients. Mol Oral Microbiol. 2015;30:227–241. 
doi:10.1111/omi.12086. 
15. Chambrone L, Preshaw PM, Rosa EF, Heasman PA, Romito GA, Pannuti CM, et al. Effects 
of smoking cessation on the outcomes of non-surgical periodontal therapy: a systematic 
review and individual patient data meta-analysis. J Clin Periodontol. 2013;40:607–615. 
doi:10.1111/jcpe.12106. 
16. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 
2007;44:127–153. doi:10.1111/j.1600-0757.2006.00193.x. 
17. Casarin RCV, Barbagallo A, Meulman T, Santos VR, Sallum EA, Nociti FH, et al. 
Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic 
periodontitis. J Periodontal Res. 2013;48:30–36. doi:10.1111/j.1600-0765.2012.01498.x. 
18. Sanz M, Ceriello A, Buysschaert M, Chapple I, Demmer RT, Graziani F, et al. 
TEMPORARY REMOVAL: Scientific evidence on the links between periodontal 
diseases and diabetes: Consensus report and guidelines of the joint workshop on 
periodontal diseases and diabetes by the International diabetes Federation and the 
European Federation of Periodontology. Diabetes Res Clin Pract. 2017. 
doi:10.1016/j.diabres.2017.12.001. 
19. Pumerantz AS, Bissett SM, Dong F, Ochoa C, Wassall RR, Davila H, et al. Standardized 
screening for periodontitis as an integral part of multidisciplinary management of adults 
with type 2 diabetes: an observational cross-sectional study of cohorts in the USA and 
UK. BMJ Open Diabetes Res Care. 2017;5:e000413. doi:10.1136/bmjdrc-2017-000413. 
20. McGowan T, McGowan K, Ivanovski S. A Novel Evidence-Based Periodontal Prognosis 
Model. J Evid Based Dent Pract. 2017;17:350–360. doi:10.1016/j.jebdp.2017.05.006. 
21. Offenbacher S, Divaris K, Barros SP, Moss KL, Marchesan JT, Morelli T, et al. Genome-
wide association study of biologically informed periodontal complex traits offers novel 
insights into the genetic basis of periodontal disease. Hum Mol Genet. 2016;25:2113–
2129. doi:10.1093/hmg/ddw069. 
22. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 
to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin 
Immunol. 2011;127:701–21.e1. doi:10.1016/j.jaci.2010.11.050. 
23. Da Silva FRP, Pessoa LDS, Vasconcelos ACCG, de Aquino Lima W, Alves EHP, 
Vasconcelos DFP. Polymorphisms in interleukins 17A and 17F genes and periodontitis: 
results from a meta-analysis. Mol Biol Rep. 2017;44:443–453. doi:10.1007/s11033-017-
4128-x. 
24. Deng J-S, Qin P, Li X-X, Du Y-H. Association between interleukin-1β C (3953/4)T 
polymorphism and chronic periodontitis: evidence from a meta-analysis. Hum Immunol. 
2013;74:371–378. doi:10.1016/j.humimm.2012.11.018. 
58 
25. Nibali L, Tonetti MS, Ready D, Parkar M, Brett PM, Donos N, et al. Interleukin-6
polymorphisms are associated with pathogenic bacteria in subjects with periodontitis. J 
Periodontol. 2008;79:677–683. doi:10.1902/jop.2008.070453. 
26. Online Mendelian Inheritance in Man Entry Search - periodontitis.
https://www.omim.org/search/?index=entry&sort=score+desc%2C+prefix_sort+desc&sta
rt=1&limit=10&search=periodontitis. Accessed 15 Feb 2018. 
27. ClinVar Entry Search - periodontitis.
https://www.ncbi.nlm.nih.gov/clinvar/?term=periodontitis. Accessed 15 Feb 2018. 
28. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public
archive of relationships among sequence variation and human phenotype. Nucleic Acids 
Res. 2014;42 Database issue:D980–5. doi:10.1093/nar/gkt1113. 
29. Haim-Munk Syndrome - NORD (National Organization for Rare Disorders).
https://rarediseases.org/rare-diseases/haim-munk-syndrome/. Accessed 15 Feb 2018. 
30. Cathepsin C; CTSC. Online Mendelian Inheritance in Man.
https://www.omim.org/entry/602365?search=periodontitis&highlight=periodontiti#text. 
Accessed 15 Feb 2018. 
31. Papillon-Lefevre Snydrome; PALS. Online Mendelian Inheritance in Man.
https://www.omim.org/clinicalSynopsis/245000?highlight=periodontiti. Accessed 15 Feb 
2018. 
32. Periodontal Disease | Division of Oral Health | Centers for Disease Control and Prevention.
https://www.cdc.gov/oralhealth/periodontal_disease/index.htm. Accessed 22 Nov 2017. 
33. Schaefer AS, Richter GM, Groessner-Schreiber B, Noack B, Nothnagel M, El Mokhtari N-E,
et al. Identification of a shared genetic susceptibility locus for coronary heart disease and 
periodontitis. PLoS Genet. 2009;5:e1000378. doi:10.1371/journal.pgen.1000378. 
34. Oral Health | Healthy People 2020. https://www.healthypeople.gov/2020/topics-
objectives/topic/oral-health. Accessed 2 Oct 2017. 
35. Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, et al. Update on
Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J 
Periodontol. 2015;86:611–622. doi:10.1902/jop.2015.140520. 
36. Eke PI, Thornton-Evans GO, Wei L, Borgnakke WS, Dye BA. Accuracy of NHANES
periodontal examination protocols. J Dent Res. 2010;89:1208–1213. 
doi:10.1177/0022034510377793. 
37. Centers for Disease Control and Prevention - Heart Disease Home - DHDSP.
https://www.cdc.gov/heartdisease/index.htm. Accessed 16 Nov 2017. 
38. Coronary Artery Disease: Causes, Diagonosis & Prevention| cdc.gov.
https://www.cdc.gov/heartdisease/coronary_ad.htm. Accessed 10 Dec 2017. 
39. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med.
2005;352:1685–1695. doi:10.1056/NEJMra043430. 
 59 
40. Hanson MA, Fareed MT, Argenio SL, Agunwamba AO, Hanson TR. Coronary artery 
disease. Prim Care. 2013;40:1–16. doi:10.1016/j.pop.2012.12.001. 
41. Hypertension - National Library of Medicine - PubMed Health. 
https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024199/. Accessed 17 Dec 2017. 
42. Hypertension (Normal Vs. High Blood Pressure) | Cleveland Clinic: Health Library. 
https://my.clevelandclinic.org/health/articles/hypertension-high-blood-pressure. Accessed 
10 Dec 2017. 
43. Risk Factors for Coronary Artery Disease | Cleveland Clinic. 
https://my.clevelandclinic.org/health/articles/coronary-artery-disease/diagnosis-risk-
factors. Accessed 10 Dec 2017. 
44. Family History & Your Risk for Heart Disease | cdc.gov. 
https://www.cdc.gov/heartdisease/family_history.htm. Accessed 10 Dec 2017. 
45. Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and 
myocardial infarction. Clin Res Cardiol. 2007;96:1–7. doi:10.1007/s00392-006-0447-y. 
46. ClinVar Entry Search - coronary artery disease. 
https://www.ncbi.nlm.nih.gov/clinvar/?term=coronary+artery+disease. Accessed 12 Feb 
2018. 
47. ClinVar Entry Search - hypertension. 
https://www.ncbi.nlm.nih.gov/clinvar/?term=hypertension. Accessed 13 Feb 2018. 
48. Online Mendelian Inheritance in Man Entry Search - hypertension. 
https://www.omim.org/search/?index=entry&sort=score+desc%2C+prefix_sort+desc&sta
rt=1&limit=10&search=hypertension. Accessed 13 Feb 2018. 
49. International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret GB, 
Munroe PB, Rice KM, Bochud M, Johnson AD, et al. Genetic variants in novel pathways 
influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103–109. 
doi:10.1038/nature10405. 
50. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, et al. Genetic variants 
influencing circulating lipid levels and risk of coronary artery disease. Arterioscler 
Thromb Vasc Biol. 2010;30:2264–2276. doi:10.1161/ATVBAHA.109.201020. 
51. Basso F, Lowe GDO, Rumley A, McMahon AD, Humphries SE. Interleukin-6 -174G>C 
polymorphism and risk of coronary heart disease in West of Scotland coronary 
prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol. 2002;22:599–604. 
52. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, Kane JP, et al. Prediction of 
coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in 
Communities Study. Am J Epidemiol. 2007;166:28–35. doi:10.1093/aje/kwm060. 
53. Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, et al. Impact of 
intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the 
diabetes prevention program. Diabetes Care. 2005;28:888–894. 
doi:10.2337/diacare.28.4.888. 
 60 
54. Tuteja S, Limdi N. Pharmacogenetics in cardiovascular medicine. Curr Genet Med Rep. 
2016;4:119–129. doi:10.1007/s40142-016-0096-z. 
55. K Siddiqui M, Maroteau C, Veluchamy A, Tornio A, Tavendale R, Carr F, et al. A common 
missense variant of LILRB5 is associated with statin intolerance and myalgia. Eur Heart 
J. 2017;38:3569–3575. doi:10.1093/eurheartj/ehx467. 
56. Johnson JA, Cavallari LH. Pharmacogenetics and cardiovascular disease--implications for 
personalized medicine. Pharmacol Rev. 2013;65:987–1009. doi:10.1124/pr.112.007252. 
57. Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML. Impact of multiple risk factor profiles 
on determining cardiovascular disease risk. Prev Med. 1998;27:1–9. 
doi:10.1006/pmed.1997.0268. 
58. Irony TZ. The “utility” in composite outcome measures: measuring what is important to 
patients. JAMA. 2017;318:1820–1821. doi:10.1001/jama.2017.14001. 
59. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction 
of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847. 
doi:10.1161/01.CIR.97.18.1837. 
60. Murphy SL, Kochanek KD, Xu J, Arias E. Mortality in the united states, 2014. NCHS Data 
Brief. 2015;:1–8. 
61. FastStats - Heart Disease. https://www.cdc.gov/nchs/fastats/heart-disease.htm. Accessed 18 
Mar 2018. 
62. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease 
and stroke statistics--2015 update: a report from the American Heart Association. 
Circulation. 2015;131:e29–322. doi:10.1161/CIR.0000000000000152. 
63. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. 
Forecasting the future of cardiovascular disease in the United States: a policy statement 
from the American Heart Association. Circulation. 2011;123:933–944. 
doi:10.1161/CIR.0b013e31820a55f5. 
64. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al. The American 
Journal of Cardiology and Journal of Periodontology editors’ consensus: periodontitis 
and atherosclerotic cardiovascular disease. J Periodontol. 2009;80:1021–1032. 
doi:10.1902/jop.2009.097001. 
65. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. 
Periodontal disease and atherosclerotic vascular disease: does the evidence support an 
independent association?: a scientific statement from the American Heart Association. 
Circulation. 2012;125:2520–2544. doi:10.1161/CIR.0b013e31825719f3. 
66. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and 
cardiovascular disease. J Periodontol. 1996;67 10 Suppl:1123–1137. 
doi:10.1902/jop.1996.67.10s.1123. 
 61 
67. Slocum C, Kramer C, Genco CA. Immune dysregulation mediated by the oral microbiome: 
potential link to chronic inflammation and atherosclerosis. J Intern Med. 2016;280:114–
128. doi:10.1111/joim.12476. 
68. D’Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein-associated 
cardiovascular risk. J Periodontal Res. 2004;39:236–241. doi:10.1111/j.1600-
0765.2004.00731.x. 
69. Bale BF, Doneen AL, Vigerust DJ. High-risk periodontal pathogens contribute to the 
pathogenesis of atherosclerosis. Postgrad Med J. 2017;93:215–220. 
doi:10.1136/postgradmedj-2016-134279. 
70. Hayashi C, Papadopoulos G, Gudino CV, Weinberg EO, Barth KR, Madrigal AG, et al. 
Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection 
with a common oral pathogen. J Immunol. 2012;189:3681–3688. 
doi:10.4049/jimmunol.1201541. 
71. Beutler BA. TLRs and innate immunity. Blood. 2009;113:1399–1407. doi:10.1182/blood-
2008-07-019307. 
72. Li L, Messas E, Batista EL, Levine RA, Amar S. Porphyromonas gingivalis infection 
accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-
deficient murine model. Circulation. 2002;105:861–867. 
73. Lindy O, Suomalainen K, Mäkelä M, Lindy S. Statin use is associated with fewer periodontal 
lesions: A retrospective study. BMC Oral Health. 2008;8:16. doi:10.1186/1472-6831-8-
16. 
74. Jockel-Schneider Y, Bechtold M, Haubitz I, Störk S, Fickl S, Harks I, et al. Impact of 
antiinfective periodontal therapy on parameters of vascular health. J Clin Periodontol. 
2017. doi:10.1111/jcpe.12849. 
75. Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, Periodontal 
Disease, and Treatment with Resolvins. Curr Atheroscler Rep. 2017;19:57. 
doi:10.1007/s11883-017-0696-4. 
76. Yu Y-H, Chasman DI, Buring JE, Rose L, Ridker PM. Cardiovascular risks associated with 
incident and prevalent periodontal disease. J Clin Periodontol. 2015;42:21–28. 
doi:10.1111/jcpe.12335. 
77. Mucci LA, Hsieh C-C, Williams PL, Arora M, Adami H-O, de Faire U, et al. Do genetic 
factors explain the association between poor oral health and cardiovascular disease? A 
prospective study among Swedish twins. Am J Epidemiol. 2009;170:615–621. 
doi:10.1093/aje/kwp177. 
78. Schaefer AS, Bochenek G, Jochens A, Ellinghaus D, Dommisch H, Güzeldemir-Akçakanat 
E, et al. Genetic evidence for PLASMINOGEN as a shared genetic risk factor of 
coronary artery disease and periodontitis. Circ Cardiovasc Genet. 2015;8:159–167. 
doi:10.1161/CIRCGENETICS.114.000554. 
79. Oral Health Studies | School of Dental Medicine | University of Pittsburgh. 
http://www.dental.pitt.edu/oral-health-studies. Accessed 30 Nov 2017. 
 62 
80. Appalachian Region of US.png - Wikimedia Commons. 
https://commons.wikimedia.org/wiki/File:Appalachian_Region_of_US.png. Accessed 19 
Mar 2018. 
81. Polk DE, Weyant RJ, Crout RJ, McNeil DW, Tarter RE, Thomas JG, et al. Study protocol of 
the Center for Oral Health Research in Appalachia (COHRA) etiology study. BMC Oral 
Health. 2008;8:18. doi:10.1186/1472-6831-8-18. 
82. C O H R A Research Procedures. Research Protocol Manual. 
83. Shaffer JR, Polk DE, Wang X, Feingold E, Weeks DE, Lee M-K, et al. Genome-wide 
association study of periodontal health measured by probing depth in adults ages 18-49 
years. G3 (Bethesda). 2014;4:307–314. doi:10.1534/g3.113.008755. 
84. Shungin D, Cornelis MC, Divaris K, Holtfreter B, Shaffer JR, Yu Y-H, et al. Using genetics 
to test the causal relationship of total adiposity and periodontitis: Mendelian 
randomization analyses in the Gene-Lifestyle Interactions and Dental Endpoints (GLIDE) 
Consortium. Int J Epidemiol. 2015;44:638–650. doi:10.1093/ije/dyv075. 
85. Wiener RC. Relationship of Edentulism, Sleep Disordered Breathing and Cardiovascular 
Disease: NHANES, 2007-2008. Cardiol Angiol. 2015;3:167–174. 
doi:10.9734/CA/2015/17944. 
86. Illumina, Inc. Illumina. Computer software. San Diego, CA: Illumina; 2018. 
87. PubMed. PubMed. https://www.ncbi.nlm.nih.gov/pubmed. Accessed 17 Feb 2018. 
88. Reference SNP (refSNP) Cluster Report: rs10864294                 . 
https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10864294. Accessed 19 Feb 
2018. 
89. Reference SNP (refSNP) Cluster Report: rs4252120                 . 
https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4252120. Accessed 19 Feb 
2018. 
90. Reference SNP (refSNP) Cluster Report: rs1800795                 **Clinical Channel**. 
https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1800795. Accessed 19 Feb 
2018. 
91. Reference SNP (refSNP) Cluster Report: rs10965215                 . 
https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10965215. Accessed 19 Feb 
2018. 
92. StataCorp. STATA. Computer software. College Station, TX: StataCorp, LLC; 2017. 
93. USC. Quanto. Computer software. California: University of Southern California; 2009. 
94. Detail view for rs1800795. HaploReg. 
http://archive.broadinstitute.org/mammals/haploreg/detail_v4.1.php?query=&id=rs18007
95. Accessed 19 Mar 2018. 
95. Interleukin 6; IL6. OMIM. https://www.omim.org/entry/147620#0001. Accessed 17 Feb 
2018. 
 63 
96. 173350: Plasminogen; PLG. Online Mendelian Inheritance in Man. 
https://www.omim.org/entry/173350?search=plg&highlight=plg. Accessed 3 Mar 2018. 
97. Detail view for rs4252120. HaploReg. 
http://archive.broadinstitute.org/mammals/haploreg/detail_v4.1.php?query=&id=rs42521
20. Accessed 19 Mar 2018. 
98. Congrains A, Kamide K, Ohishi M, Rakugi H. ANRIL: molecular mechanisms and 
implications in human health. Int J Mol Sci. 2013;14:1278–1292. 
doi:10.3390/ijms14011278. 
99. 600431: Cyclin-Dependent Kinase Inhibitory 2B; CDKN2A. Online Mendelian Inheritance 
in Man. https://www.omim.org/entry/600431?search=cdkn2b&highlight=cdkn2b. 
Accessed 3 Mar 2018. 
100. 600160: Cyclin-Dependent Kinase Inhibitor 2A; CDKN2A. Online Mendelian Inheritance 
in Man. https://www.omim.org/entry/600160?search=cdkn2a&highlight=cdkn2a. 
Accessed 3 Mar 2018. 
101. 613149: CDKN2B Antisense RNA: CDKN2BAS. Online Mendelian Inheritance in Man. 
https://www.omim.org/entry/613149?search=anril&highlight=anril. Accessed 3 Mar 
2018. 
102. Detail view for rs10965215. HaploReg. 
http://archive.broadinstitute.org/mammals/haploreg/detail_v4.1.php?query=&id=rs10965
215. Accessed 19 Mar 2018. 
103. 603657: Vesicle-Associated Membrane Protein 3; VAMP3. Online Mendelian Inheritance 
in Man. https://www.omim.org/entry/603657?search=vamp3&highlight=vamp3. 
Accessed 3 Mar 2018. 
104. 611501: Calmodulin-Binding Transcription Activator 1; CAMTA1. Online Mendelian 
Inheritance in Man. 
https://www.omim.org/entry/611501?search=camta1&highlight=camta1. Accessed 3 Mar 
2018. 
105. Wey E, Schäfer BW. Identification of novel DNA binding sites recognized by the 
transcription factor mPOU (POU6F1). Biochem Biophys Res Commun. 1996;220:274–
279. doi:10.1006/bbrc.1996.0395. 
106. Detail view for rs10864294. HaploReg. 
http://archive.broadinstitute.org/mammals/haploreg/detail_v4.1.php?query=&id=rs10864
294. Accessed 19 Mar 2018. 
107. Divaris K, Monda KL, North KE, Olshan AF, Lange EM, Moss K, et al. Genome-wide 
association study of periodontal pathogen colonization. J Dent Res. 2012;91 7 
Suppl:21S–28S. doi:10.1177/0022034512447951. 
108. National Research Council (US) and Institute of Medicine (US) Roundtable on Translating 
Genomic-Based Research for Health. Currently Available Direct-to-Consumer Genetic 
Tests. 2010. 
 64 
109. Access to Health Services | Healthy People 2020. 
https://www.healthypeople.gov/2020/topics-objectives/topic/Access-to-Health-Services. 
Accessed 13 Apr 2018. 
110. Reports C, Reports C. Health Insurance Coverage in the United States: 2015. 
111. Rai R, Naveen Kumar PG, Hirekalmath S, Sunil LA. Genetics and oral health. Dent Med 
Res. 2016;4:9. doi:10.4103/2348-1471.171918. 
112. Centers for Disease Control and Prevention - Public Health System and the 10 Essential 
Public Health Services - OSTLTS. 
https://www.cdc.gov/stltpublichealth/publichealthservices/essentialhealthservices.html. 
Accessed 28 Feb 2018. 
113. Fantasia JE. Syndromes with unusual dental findings or gingival components. Atlas Oral 
Maxillofac Surg Clin North Am. 2014;22:211–219. doi:10.1016/j.cxom.2014.05.006. 
 
